Publikationsliste 2022
Alffenaar JWC, Stocker SL, Forsman LD, Garcia-Prats A, Heysell SK, Aarnoutse RE, Akkerman OW, Aleksa A, van Altena R, de Oñata WA, Bhavani PK, Van't Boveneind-Vrubleuskaya N, Carvalho ACC, Centis R, Chakaya JM, Cirillo DM, Cho JG, L DA, Dalcolmo MP, Denti P, Dheda K, Fox GJ, Hesseling AC, Kim HY, Köser CU, Marais BJ, Margineanu I, Märtson AG, Torrico MM, Nataprawira HM, Ong CWM, Otto-Knapp R, Peloquin CA, Silva DR, Ruslami R, Santoso P, Savic RM, Singla R, Svensson EM, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas TA, Udwadia ZF, Vu DH, Zhang W, Mpagama SG, Schön T, Migliori GB. Clinical standards for the dosing and management of TB drugs. Int J Tuberc Lung Dis. 2022;26(6):483-99. PubMed PMID 35650702
Baum P, Lenzi J, Diers J, Rust C, Eichhorn ME, Taber S, Germer CT, Winter H, Wiegering A. Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data. J Clin Oncol. 2022;40(10):1041-50. PubMed PMID 35015575
Baum P, Lenzi J, Taber S, Winter H, Wiegering A. Reply to A. Saraswathula et al and Z.V. Fong et al. J Clin Oncol. 2022;40(25):2998-3000.
Baum P, Lenzi J, Taber S, Winter H, Wiegering A. Quality versus quantity in surgical oncology – what is the future? Nature reviews Clinical oncology. 2022. PubMed PMID 35264771
Baum P, Winter H, Eichhorn ME, Roesch RM, Taber S, Christopoulos P, Wiegering A, Lenzi J. Trends in age- and sex-specific lung cancer mortality in Europe and Northern America: Analysis of vital registration data from the WHO Mortality Database between 2000 and 2017. Eur J Cancer. 2022;171:269-79. PubMed PMID 35738973
Bertrams W, Hönzke K, Obermayer B, Tönnies M, Bauer TT, Schneider P, Neudecker J, Rückert JC, Stiewe T, Nist A, Eggeling S, Suttorp N, Wolff T, Hippenstiel S, Schmeck B, Hocke AC. Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virus. Sci Rep. 2022;12(1):20608. PubMed PMID 36446841
Blum TG, Morgan RL, Durieux V, Chorostowska-Wynimko J, Baldwin DR, Boyd J, Faivre- Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hardavella G, Hauptmann M, Jakobsen E, Jovanovic D, Knaut P, Massard G, McPhelim J, Meert AP, Milroy R, Muhr R, Mutti L, Paesmans M, Powell P, Putora PM, Rawlinson J, Rich AL, Rigau D, de Ruysscher D, Sculier JP, Schepereel A, Subotic D, Van Schil P, Tonia T, Williams C, Berghmans T. European Respiratory Society Guideline on various aspects of quality in lung cancer care. Eur Respir J. 2022. PubMed PMID 36396145
Bonsignore M, Hohenstein S, Kodde C, Leiner J, Schwegmann K, Bollmann A, Möller R, Kuhlen R, Nachtigall I. Burden of Hospital-acquired SARS-CoV-2 Infections in Germany. J Hosp Infect. 2022. PubMed PMID 35995339
Bonsignore M, Hohenstein S, Kodde C, Leiner J, Schwegmann K, Bollmann A, Möller R, Kuhlen R, Nachtigall I. The Disease Course of Hospitalized COVID-19 Patients During the Delta and Omicron Periods in Consideration of Vaccination Status. Dtsch Arztebl Int. 2022;119(35-36):605-6. PubMed PMID 36474339
Brinkmann F, Feiterna-Sperling C, Günther A, Breuer C, Hartmann P, Hufnagel M, Priwitzer M, Otto-Knapp R, Witte P, Diel R, Häcker B. Untersuchung auf Tuberkulose bei geflüchteten Kindern und Jugendlichen aus der Ukraine. Pneumologie. 2022;76(7):479-84. PubMed PMID 35609817
Christopoulos P, Kluck K, Kirchner M, Lüders H, Roeper J, Falkenstern-Ge RF, Szewczyk M, Sticht F, Saalfeld FC, Wesseler C, Hackanson B, Dintner S, Faehling M, Kuon J, Janning M, Kauffmann-Guerrero D, Kazdal D, Kurz S, Eichhorn F, Bozorgmehr F, Shah R, Tufman A,
Wermke M, Loges S, Brueckl WM, Schulz C, Misch D, Frost N, Kollmeier J, Reck M, Griesinger F, Grohé C, Hong JL, Lin HM, Budczies J, Stenzinger A, Thomas M. The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. Eur J Cancer. 2022;170:106-18. PubMed PMID 35598358
European Centre for Disease Prevention and Control. Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study–first update. 2022. [Beteiligung HK Emil von Behring gelistet]
Griesinger F, Curigliano G, Thomas M, Subbiah V, Baik CS, Tan DSW, Lee DH, Misch D, Garralda E, Kim DW, van der Wekken AJ, Gainor JF, Paz-Ares L, Liu SV, Kalemkerian GP, Houvras Y, Bowles DW, Mansfield AS, Lin JJ, Smoljanovic V, Rahman A, Kong S, Zalutskaya A, Louie-Gao M, Boral AL, Mazières J. Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial. Ann Oncol. 2022;33(11):1168-78. PubMed PMID 35973665
Group AST. Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J. 2022;59(4) [Ralf Otto-Knapp German Central Committee against Tuberculosis, Berlin, Germany gelistet]. PubMed PMID 35422426
Hoffmann K, Obermayer B, Honzke K, Fatykhova D, Demir Z, Lowa A, Alves LGT, Wyler E, Lopez-Rodriguez E, Mieth M, Baumgardt M, Hoppe J, Firsching TC, Tonnies M, Bauer TT, Eggeling S, Tran HL, Schneider P, Neudecker J, Ruckert JC, Gruber AD, Ochs M, Landthaler M, Beule D, Suttorp N, Hippenstiel S, Hocke AC, Kessler M. Human alveolar progenitors generate dual lineage bronchioalveolar organoids. Commun Biol. 2022;5(1):875. PubMed PMID 36008580
Hönzke K, Obermayer B, Mache C, Fathykova D, Kessler M, Dökel S, Wyler E, Baumgardt M, Löwa A, Hoffmann K, Graff P, Schulze J, Mieth M, Hellwig K, Demir Z, Biere B, Brunotte L, Mecate-Zambrano A, Bushe J, Dohmen M, Hinze C, Elezkurtaj S, Tönnies M, Bauer TT, Eggeling S, Tran HL, Schneider P, Neudecker J, Rückert JC, Schmidt-Ott KM, Busch J, Klauschen F, Horst D, Radbruch H, Radke J, Heppner F, Corman VM, Niemeyer D, Müller MA, Goffinet C, Mothes R, Pascual-Reguant A, Hauser AE, Beule D, Landthaler M, Ludwig S, Suttorp N, Witzenrath M, Gruber AD, Drosten C, Sander LE, Wolff T, Hippenstiel S, Hocke AC. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Eur Respir J. 2022. PubMed PMID 35728978
Igbokwe V, Häcker B, Otto-Knapp R, Bauer T. Tuberkulose-Gefahr steigt. Heilberufe. 2022;74:2.
Kodde C, Bonsignore M, Schöndube D, Bauer T, Hohenstein S, Bollmann A, Meier-Hellmann A, Kuhlen R, Nachtigall I. Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network. Infection. 2022:1-9. PubdMed PMID 35657531
Koerber MK, Agaoglu S, Bichmann A, Tafelski S, Nachtigall I. Female Patients with Pneumonia on Intensive Care Unit Are under Risk of Fatal Outcome. Medicina (Kaunas). 2022;58(6). PubMed PMID 35744090
König S, Hohenstein S, Pellissier V, Leiner J, Hindricks G, Nachtigall I, Kuhlen R, Bollmann A. Changing trends of patient characteristics and treatment pathways during the COVID-19 pandemic: A cross-sectional analysis of 72,459 inpatient cases from the German Helios database. Front Public Health. 2022;10:1028062. PubMed PMID 36420010
Leiner J, Pellissier V, Hohenstein S, König S, Schuler E, Möller R, Nachtigall I, Bonsignore M, Hindricks G, Kuhlen R, Bollmann A. Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals. BMC Infect Dis. 2022;22(1):802. PubMed PMID 36303111
Leiner J, Pellissier V, König S, Hohenstein S, Ueberham L, Nachtigall I, Meier-Hellmann A, Kuhlen R, Hindricks G, Bollmann A. Machine learning-derived prediction of in-hospital mortality in patients with severe acute respiratory infection: analysis of claims data from the
German-wide Helios hospital network. Respir Res. 2022;23(1):264. PubMed PMID 36151525
Lenga P, Grah C, Ruwwe-Glösenkamp C, Saccomanno J, Rückert J, Eggeling S, Gläser S, Kurz S, Eisenmann S, Krüger M, Schmidt B, Schneider P, Andreas S, Hinterthaner M, Pfannschmidt J, Gebhardt A, Stanzel F, Holland A, Kirschbaum A, Becke B, Hübner RH. Endoscopic Lung Volume Reduction with One-Way Valves in Patients with Severe Chronic Obstructive Pulmonary Disease with Hypercapnia. Respiration. 2022;101(9):823-32. PubMed PMID 35785772
Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-Fenge H, Otto-Knapp R, Hacker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer J, Worth H, Windisch W, Welte T, Bauer T. Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians. Respiration. 2022;101(3):307-20. PubMed PMID 35231915
Mantei A, Meyer T, Schurmann M, Bessler C, Bias H, Krieger D, Bauer T, Bacher P, Helmuth J, Volk HD, Schurmann D, Scheffold A, Meisel C. Mycobacterium tuberculosis-specific CD4 T-cell scoring discriminates tuberculosis infection from disease. Eur Respir J. 2022;60(1):2101780. PubMed PMID 35618277
Nachtigall I, Bonsignore M, Hohenstein S, Bollmann A, Günther R, Kodde C, Englisch M, Ahmad-Nejad P, Schröder A, Glenz C, Kuhlen R, Thürmann P, Meier-Hellmann A. Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers. BMC Infect Dis. 2022;22(1):291. PubMed PMID 35346089
Nadal E, Horinouchi H, Shih JY, Nakagawa K, Reck M, Garon EB, Wei YF, Kollmeier J, Frimodt-Moller B, Barrett E, Lipkovich O, Visseren-Grul C, Novello S. RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability. Drug Saf. 2022;45(1):45-64. PubMed PMID 34928484
Othmer JT, Schoenfeld N, Roth A, Vesenbeckh MS, Bauer T, Mauch H. Kavernöse nichttuberkulöse Mykobakteriose der Lunge durch M. heckeshornense bei einem HIV-infizierten Patienten. Pneumologie. 2022;76(8):568-72. PubMed PMID 35488173
Otto-Knapp R, Häcker B, Krieger D, Stete K, Starzacher K, Maier C, Heyckendorf J, Avsar K, Suárez I, Rybniker J, Bauer T, Günther G, Lange C. Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany. Eur Respir J. 2022;60(5). PubMed PMID 36423919
Pennitz P, Kirsten H, Friedrich VD, Wyler E, Goekeri C, Obermayer B, Heinz GA, Mashreghi MF, Büttner M, Trimpert J, Landthaler M, Suttorp N, Hocke AC, Hippenstiel S, Tönnies M, Scholz M, Kuebler WM, Witzenrath M, Hoenzke K, Nouailles G. A pulmonologist's guide to
perform and analyse cross-species single lung cell transcriptomics. Eur Respir Rev. 2022;31(165). PubMed PMID 35896273
Pfannschmidt J, Guckenberger M, Eberhardt WEE. Konzepte beim oligometastasierten Lungenkarzinom. Die Onkologie. 2022;28(12):1078-86.
Rihs HP, Casjens S, Raiko I, Kollmeier J, Lehnert M, Nöfer K, May-Taube K, Kaiser N, Taeger D, Behrens T, Brüning T, Johnen G. Mesothelin Gene Variants Affect Soluble Mesothelin-Related Protein Levels in the Plasma of Asbestos-Exposed Males and Mesothelioma Patients from Germany. Biology (Basel). 2022;11(12). PubMed PMID 36552335
Schaberg T, Brinkmann F, Feiterna-Sperling C, Geerdes-Fenge H, Hartmann P, Häcker B, Hauer B, Haas W, Heyckendorf J, Lange C, Maurer FP, Nienhaus A, Otto-Knapp R, Priwitzer M, Richter E, Salzer HJF, Schoch O, Schönfeld N, Stahlmann R, Bauer T. Tuberkulose im Erwachsenenalter. Pneumologie. 2022;76(11):727-819. PubMed PMID 36384164
Slevogt H, Bauer T. Von Alpha bis Omikron: Das 3. Jahr der COVID-19-Pandemie. Kompass Pneumologie. 2022;10(1):4-5.
Stephan-Falkenau S, Streubel A, Mairinger T, Kollmeier J, Misch D, Thiel S, Bauer T, Pfannschmidt J, Hollmann M, Wessolly M, Blum TG. Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study. International journal of molecular sciences. 2022;23(20). PubMed PMID 36293366
Taber S, Pfannschmidt J, Bauer TT, Blum TG, Grah C, Griff S. Is Adjuvant Radiochemotherapy Always Mandatory in Patients with Resected N2 Non-Small Cell Lung Cancer? Thorac Cardiovasc Surg. 2022;70(3):244-50. PubMed PMID 33601469
Tafelski S, Lange M, Wegener F, Gratopp A, Spies C, Wernecke KD, Nachtigall I. Pneumonia in pediatric critical care medicine and the adherence to guidelines. Minerva Pediatr (Torino). 2022;74(4):447-54. PubMed PMID 31621272
Toy HI, Misch D, Stephan-Falkenau S, Althoff CE, Gebhard A, Bauer TT, Kollmeier J. Unilateral bullous emphysema after successful treatment of a malignant pleural mesothelioma with combined CTLA-4 and PD-1 blockade. J Clin Images Med Case Rep. 2022;5(5):2.
Uporov A, Taber S, Estèvez Schwarz L, Groene J, Pilz LR, Foerster G, Bittner R, Pfannschmidt J. Implication of FDG-PET/CT in patients with potentially operable colorectal lung metastases. Innov Surg Sci. 2022;6(3):89-95. PubMed PMID: 35224176
Wessolly M, Stephan-Falkenau S, Streubel A, Wiesweg M, Borchert S, Mairinger E, Kollmeier J, Reis H, Bauer T, Schmid KW, Mairinger T, Schuler M, Mairinger FD. Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy. BMC Cancer. 2022;22(1):46. PubMed PMID: 34996407
Zoair M, Taber S, Bittner R, Foerster G, Griff S, Bauer TT, Pfannschmidt J. Value of (18)F FDG-PET/CT parameters on long term follow-up for patients with non-small cell lung cancer. Innov Surg Sci. 2022;7(2):35-43. PubMed PMID: 36317010